| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.5 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.14 | 0.5 |